In a unanimous opinion issued Thursday, June 1, the U.S. Supreme Court retained the current “scienter” or “knowledge standard” governing False Claims Act (“FCA”) cases, and, in doing so, offered guidance to [...]
Winter is coming. No, it’s not the motto of House Stark of Westeros, it’s Jane Winter—a former hospital Care Management Director turned whistleblower—and her qui tam action, plowing new ground on the falsity [...]
On March 3, 2020, the Department of Justice (DOJ) launched a National Nursing Home Initiative to “coordinate and enhance civil and criminal efforts to pursue nursing homes and long-term care facilities that provide [...]
On Presidents’ Day, the Court of Appeals for the Fifth Circuit reminded us that Lincoln’s Law still packs quite the punch. In a decision issued on Monday, the Fifth Circuit affirmed summary judgment [...]
On February 7, 2020, the U.S. Court of Appeals for the Tenth Circuit affirmed summary judgment for the defendant hospital in a False Claims Act (“FCA”) case premised on falsified data. The case—United [...]
The United States Environmental Protection Agency (EPA) has a new Inspector General (IG), following an extended period of oversight by acting IGs. Sean O’Donnell was confirmed on December 19, 2019 to lead the [...]
Yesterday, Judge Chen of the U.S. District Court for the Northern District of California dismissed claims alleging that Gilead Sciences, Inc. defrauded the United States government and violated the False Claims Act (FCA) [...]
Washington, DC – Feldesman Tucker Leifer Fidell LLP (FTLF) is pleased to announce the addition of former Department of Justice attorney Rosie Dawn Griffin to its Federal Litigation and Government Investigations practice. Ms. [...]
We previously reported about a group of False Claims Act (“FCA”) cases brought by the National Healthcare Analysis Group (“NHCA”), a Wall Street funded “professional relator” that has filed nearly a dozen FCA cases [...]
The National Institutes of Health (“NIH”) recently issued guidance related to the disclosure of “other support,” “foreign components,” and “financial conflicts of interest” for NIH grantees. The new guidance, issued on July 10, [...]
